News for IDEXX Laboratories, Inc. (IDXX.MX)

We recently published a list of Jim Cramer’s Thoughts on These 10 Stocks. In this article, we are going to take a look at where IDEXX Laboratories, Inc.

On May 19, 2025, Stifel analyst Jonathan Block decided to maintain a "Hold" rating for IDEXX Laboratories (IDXX), a prominent player in the diagnostic and IT so

IDEXX Laboratories, Inc. reports strong Q1 FY25 growth with 4.7% organic revenue. Click for my updated look at IDXX stock post earnings.

IDEXX Laboratories (IDXX) executives to participate in Stifel Jaws & Paws Conference on May 28, 2025. Company announces 2025 Investor Day scheduled for

IDEXX Laboratories, Inc. (IDXX) has made significant changes to its corporate structure following the 2025 Annual Meeting of Stockholders held on May 7, 2025.

Exploring the Investment Strategies of a Renowned Value Investor Wallace Weitz (Trades, Portfolio) recently submitted the 13F filing for the first quarter of 2

Baron Funds, an investment management firm, released its “Focused Growth Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. Q1 was a difficult start to the year. The fund declined 7.95% (Institutional Shares) in the quarter, compared to the Russell 2500 Growth Index’s (the Benchmark) 10.80% return. Please spare […]

On May 5, 2025, Morgan Stanley analyst Erin Wright announced an update on IDEXX Laboratories (IDXX). The analyst has maintained the "Overweight" rating for the

Stifel has revised its price target for Idexx Laboratories (IDXX), increasing it from $420 to $460 while maintaining a Hold rating on the stock. According to th

Key Highlights: IDEXX Laboratories (IDXX) reports a strong Q1 2025 revenue of $998.4 million, marking a 4% increase year-over-year. Wall Street analysts

IDEXX Laboratories achieves 5% organic revenue growth in Q1 2025, powered by innovative product launches. Wall Street sets a favorable one-year price ta

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2025 Earnings Conference Call May 1, 2025 8:30 AM ETCompany ParticipantsAndrew Emerson - EVP, CFO and TreasurerJay...

Revenue: $998 million for Q1 2025, slightly below the estimated $998.15 million, marking a 4% increase as reported and 5% organic growth.Earnings Per Share (EP

Baron Focused Growth Fund declined during the first quarter of 2025, although it outperformed its benchmark, the Russell 2500 Growth Index. Read more here.

Baron Partners Fund declined in the first quarter of 2025, underperforming its benchmark, the Russell Midcap Growth Index.

Looking into the current session, IDEXX Laboratories Inc. IDXX shares are trading at $409.49, after a 0.70% increase. Moreover, over the past month, the stock i...

IDEXX Laboratories Inc (IDXX) has recently been in the spotlight, drawing interest from investors and financial analysts due to its robust financial stance. Wit

Stifel has revised its price outlook for Idexx Laboratories (IDXX), decreasing the target from $450 to $420. This adjustment follows an in-depth survey evaluati

TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. In the fourth quarter, the strategy returned -1.35% (gross) and -1.56% (net) compared to 8.14% for the Russell Midcap Growth Index. In the fourth quarter, the U.S. small […]